section name header
Index
30
59
Abdomen
Adult
Air Travel and Prevention of Venous Thromboembolism by Medication
Anticoagulant Therapy in Acute (Duration Less Than 48 Hours) Atrial Fibrillation
Anticoagulant therapy
Anticoagulation for Cerebral Sinus Thrombosis
Anticoagulation for the Intial Treatment of Venous Thromboembolism in Patients with Cancer
Anticoagulation for the Long Term Treatment of Venous Thromboembolism in Patients with Cancer
Anticoagulation for Thrombosis Prophylaxis in Cancer Patients with Central Venous Catheters
Antiplatelet Drugs for Prevention of Restenosis after Peripheral Endovascular Treatment
Antithrombotic Agents for Preventing Thrombosis after Infrainguinal Arterial Bypass Surgery
Antithrombotic Agents in Primary Health Care - Related Resources
Antithrombotic Therapy for Women Considered at Risk of Placental Dysfunction
Aspirin or Anticoagulants for the Treatment of Recurrent Pregnancy Loss in Women Without Antiphospholipid Syndrome
Cardiology
Cochrane review
Dabigatran Versus Lmwhs for Thromboprophylaxis after Total Hip or Knee Replacement
Death
Deep Vein Thrombosis - Related Resources
Deep Venous Thrombosis Prophylaxis in Cancer Patients
Embolism
Evidence summary
Extended DVT Prophylaxis after Hospital Discharge in Patients with Elective Hip Arthroplasty
Follow-up
Fondaparinux for Acute Coronary Syndromes
Fondaparinux in the Prevention of Venous Thromboembolism after Surgery
Graduated Compression Stockings in the Prevention of Postoperative Venous Thromboembolism
Haematology
Haematology
Heparin, Low-Molecular-Weight
Heparin for Assisted Reproduction
Heparin for the Prevention of Venous Thromboembolism in General Medical Patients (Excluding Stroke and Myocardial Infarction)
Heparin
Home Versus in-Patient Treatment for Deep Vein Thrombosis
Injections
Internal medicine
Internal medicine
Interventions for Preventing Venous Thromboembolism in Adults Undergoing Knee Arthroscopy
List of Abbreviations
Low-Molecular Weight Heparin in Patients with Acute Myocardial Infarction Treated with Thrombolytic Therapy
Low Molecular Weight Heparin in Patients with Lower-Leg Immobilization
Low-Molecular-Weight Heparins (Lmwh) Versus Unfractionated Heparin for Venous Thromboembolism
Low Molecular Weight Heparins for Acute Coronary Syndromes
Low-Molecular-Weight Heparins Vs. Standard Heparin for Acute Ischaemic Stroke
Lung Cancer - Related Resources
Meta-analysis
Mortality
Once Daily Vs Twice Daily Low Molecular Weight Heparin (Lmwh) for Deep Vein Thrombosis
Once Versus Twice Daily Low Molecular Weight Heparin for the Initial Treatment of Venous Thromboembolism
Oral anticoagulant
Oral Direct Thrombin Inhibitors or Oral Factor Xa Inhibitors for the Treatment of Deep Vein Thrombosis
Pain
Parenteral Anticoagulation in Ambulatory Patients with Cancer
Patients
Prevention of Recurrent Miscarriage for Women with Antiphospholipid Antibody or Lupus Anticoagulant
Prevention of Venous Thromboembolism - Related Resources
Prevention
Primary Prophylaxis for Venous Thromboembolism in Ambulatory Cancer Patients Receiving Chemotherapy
Prolonged Thromboprophylaxis with Low Molecular Weight Heparin for Abdominal or Pelvic Surgery
Prophylaxis Against Deep Vein Thrombosis and Pulmonary Embolism in Hip Fracture Surgery
Pulmonary Embolism - Related Resources
Pulmonary Embolism
Risk for Heparin-Induced Thrombocytopenia (HIT) with Either Low-Molecular-Weight Heparin (Lmwh) or Unfractionated Heparin (Ufh)
Risk
Slow Versus Fast Subcutaneous Injection of Lmwh
Subcutaneous Unfractionated Heparin for the Initial Treatment of Venous Thromboembolism
Surgery
Surgery
Systematic review
Thrombocytopenia
Thromboembolism
Thromboprophylaxis for Trauma Patients
Thrombosis
Thrombus Prophylaxis in Colorectal Surgery
Treatment for Superficial Thrombophlebitis of the Leg
Treatment of Deep Venous Thrombosis
Vascular surgery
Venous thromboembolism
Venous Thrombosis
Vitamin K Antagonists or Low-Molecular Weight Heparin for Venous Thromboembolism
VTE
Warfarin Initiation Nomograms for Venous Thromboembolism
Weight